nodes	percent_of_prediction	percent_of_DWPC	metapath
Medroxyprogesterone Acetate—HSD3B2—Steroid Biosynthesis—F13B—age related macular degeneration	0.465	0.465	CbGpPWpGaD
Medroxyprogesterone Acetate—AKR1C3—Diseases associated with visual transduction—RDH8—age related macular degeneration	0.0408	0.0408	CbGpPWpGaD
Medroxyprogesterone Acetate—AKR1C3—Diseases associated with visual transduction—RPE65—age related macular degeneration	0.0356	0.0356	CbGpPWpGaD
Medroxyprogesterone Acetate—AKR1C3—Diseases associated with visual transduction—ABCA4—age related macular degeneration	0.0287	0.0287	CbGpPWpGaD
Medroxyprogesterone Acetate—AKR1C3—Diseases associated with visual transduction—RHO—age related macular degeneration	0.025	0.025	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—LKB1 signaling events—MAP2—age related macular degeneration	0.0223	0.0223	CbGpPWpGaD
Medroxyprogesterone Acetate—AR—SIDS Susceptibility Pathways—REST—age related macular degeneration	0.018	0.018	CbGpPWpGaD
Medroxyprogesterone Acetate—HSD3B2—Metabolism of lipids and lipoproteins—ELOVL4—age related macular degeneration	0.0172	0.0172	CbGpPWpGaD
Medroxyprogesterone Acetate—HSD3B2—Corticotropin-releasing hormone—TLR4—age related macular degeneration	0.0153	0.0153	CbGpPWpGaD
Medroxyprogesterone Acetate—AKR1C3—Retinoid metabolism and transport—APOE—age related macular degeneration	0.0147	0.0147	CbGpPWpGaD
Medroxyprogesterone Acetate—NR3C1—SIDS Susceptibility Pathways—REST—age related macular degeneration	0.0137	0.0137	CbGpPWpGaD
Medroxyprogesterone Acetate—AR—Integrated Breast Cancer Pathway—RHO—age related macular degeneration	0.0104	0.0104	CbGpPWpGaD
Medroxyprogesterone Acetate—AR—SIDS Susceptibility Pathways—MAP2—age related macular degeneration	0.0103	0.0103	CbGpPWpGaD
Medroxyprogesterone Acetate—HSD3B2—Metabolism—NMNAT1—age related macular degeneration	0.00878	0.00878	CbGpPWpGaD
Medroxyprogesterone Acetate—PGR—Validated nuclear estrogen receptor alpha network—C3—age related macular degeneration	0.00874	0.00874	CbGpPWpGaD
Medroxyprogesterone Acetate—AKR1C3—Metabolism of lipids and lipoproteins—ELOVL4—age related macular degeneration	0.00851	0.00851	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Integrated Breast Cancer Pathway—RHO—age related macular degeneration	0.00798	0.00798	CbGpPWpGaD
Medroxyprogesterone Acetate—NR3C1—SIDS Susceptibility Pathways—MAP2—age related macular degeneration	0.00785	0.00785	CbGpPWpGaD
Medroxyprogesterone Acetate—AR—Notch-mediated HES/HEY network—KDR—age related macular degeneration	0.00777	0.00777	CbGpPWpGaD
Medroxyprogesterone Acetate—HSD3B2—Metabolism—ELOVL4—age related macular degeneration	0.00767	0.00767	CbGpPWpGaD
Medroxyprogesterone Acetate—AKR1C3—Diseases associated with visual transduction—APOE—age related macular degeneration	0.00752	0.00752	CbGpPWpGaD
Medroxyprogesterone Acetate—HSD3B2—Metabolism of lipids and lipoproteins—LIPC—age related macular degeneration	0.00711	0.00711	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Aryl Hydrocarbon Receptor—CD36—age related macular degeneration	0.00705	0.00705	CbGpPWpGaD
Medroxyprogesterone Acetate—HSD3B2—Metabolism of lipids and lipoproteins—CETP—age related macular degeneration	0.00686	0.00686	CbGpPWpGaD
Medroxyprogesterone Acetate—HSD3B2—Metabolism—SLC16A8—age related macular degeneration	0.00618	0.00618	CbGpPWpGaD
Medroxyprogesterone Acetate—AR—Integrated Breast Cancer Pathway—TGFBR1—age related macular degeneration	0.00582	0.00582	CbGpPWpGaD
Medroxyprogesterone Acetate—AR—Integrated Pancreatic Cancer Pathway—CST3—age related macular degeneration	0.00537	0.00537	CbGpPWpGaD
Medroxyprogesterone Acetate—AKR1C3—Disease—NMNAT1—age related macular degeneration	0.00518	0.00518	CbGpPWpGaD
Medroxyprogesterone Acetate—AKR1C3—Disease—RDH8—age related macular degeneration	0.00518	0.00518	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Validated nuclear estrogen receptor alpha network—C3—age related macular degeneration	0.00513	0.00513	CbGpPWpGaD
Medroxyprogesterone Acetate—AR—Integrated Pancreatic Cancer Pathway—TGFBR1—age related macular degeneration	0.00482	0.00482	CbGpPWpGaD
Medroxyprogesterone Acetate—AKR1C3—Disease—RPE65—age related macular degeneration	0.00453	0.00453	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Integrated Breast Cancer Pathway—TGFBR1—age related macular degeneration	0.00448	0.00448	CbGpPWpGaD
Medroxyprogesterone Acetate—AKR1C3—Metabolism—NMNAT1—age related macular degeneration	0.00434	0.00434	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Integrated Pancreatic Cancer Pathway—CST3—age related macular degeneration	0.00414	0.00414	CbGpPWpGaD
Medroxyprogesterone Acetate—HSD3B2—Metabolism of lipids and lipoproteins—CD36—age related macular degeneration	0.00412	0.00412	CbGpPWpGaD
Medroxyprogesterone Acetate—AKR1C3—Metabolism—ELOVL4—age related macular degeneration	0.00379	0.00379	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—AP-1 transcription factor network—CCL2—age related macular degeneration	0.00374	0.00374	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Integrated Pancreatic Cancer Pathway—TGFBR1—age related macular degeneration	0.00371	0.00371	CbGpPWpGaD
Medroxyprogesterone Acetate—NR3C1—AP-1 transcription factor network—CCL2—age related macular degeneration	0.00368	0.00368	CbGpPWpGaD
Medroxyprogesterone Acetate—AKR1C3—Disease—ABCA4—age related macular degeneration	0.00365	0.00365	CbGpPWpGaD
Medroxyprogesterone Acetate—HSD3B2—Metabolism of lipids and lipoproteins—APOE—age related macular degeneration	0.00364	0.00364	CbGpPWpGaD
Medroxyprogesterone Acetate—AKR1C3—Signaling Pathways—RDH8—age related macular degeneration	0.00363	0.00363	CbGpPWpGaD
Medroxyprogesterone Acetate—AKR1C3—Metabolism of lipids and lipoproteins—LIPC—age related macular degeneration	0.00351	0.00351	CbGpPWpGaD
Medroxyprogesterone Acetate—AKR1C3—Metabolism of lipids and lipoproteins—CETP—age related macular degeneration	0.00339	0.00339	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Aryl Hydrocarbon Receptor—VEGFA—age related macular degeneration	0.00336	0.00336	CbGpPWpGaD
Medroxyprogesterone Acetate—PGR—Gene Expression—ERCC6—age related macular degeneration	0.00333	0.00333	CbGpPWpGaD
Medroxyprogesterone Acetate—AKR1C3—Disease—RHO—age related macular degeneration	0.00317	0.00317	CbGpPWpGaD
Medroxyprogesterone Acetate—AKR1C3—Signaling Pathways—RPE65—age related macular degeneration	0.00317	0.00317	CbGpPWpGaD
Medroxyprogesterone Acetate—HSD3B2—Metabolism—LIPC—age related macular degeneration	0.00317	0.00317	CbGpPWpGaD
Medroxyprogesterone Acetate—HSD3B2—Metabolism—CETP—age related macular degeneration	0.00305	0.00305	CbGpPWpGaD
Medroxyprogesterone Acetate—AKR1C3—Metabolism—SLC16A8—age related macular degeneration	0.00305	0.00305	CbGpPWpGaD
Medroxyprogesterone Acetate—PGR—Signaling Pathways—RDH8—age related macular degeneration	0.00286	0.00286	CbGpPWpGaD
Medroxyprogesterone Acetate—AKR1C3—Signaling Pathways—ABCA4—age related macular degeneration	0.00255	0.00255	CbGpPWpGaD
Medroxyprogesterone Acetate—AR—Gene Expression—ERCC6—age related macular degeneration	0.00254	0.00254	CbGpPWpGaD
Medroxyprogesterone Acetate—PGR—Signaling Pathways—RPE65—age related macular degeneration	0.0025	0.0025	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP2C8—Metabolism of lipids and lipoproteins—ELOVL4—age related macular degeneration	0.00239	0.00239	CbGpPWpGaD
Medroxyprogesterone Acetate—AKR1C3—Signaling Pathways—RHO—age related macular degeneration	0.00222	0.00222	CbGpPWpGaD
Medroxyprogesterone Acetate—AKR1C3—Metabolism of lipids and lipoproteins—CD36—age related macular degeneration	0.00204	0.00204	CbGpPWpGaD
Medroxyprogesterone Acetate—PGR—Signaling Pathways—ABCA4—age related macular degeneration	0.00201	0.00201	CbGpPWpGaD
Medroxyprogesterone Acetate—AKR1C3—Disease—CST3—age related macular degeneration	0.00198	0.00198	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Gene Expression—ERCC6—age related macular degeneration	0.00196	0.00196	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP2C9—Metabolism of lipids and lipoproteins—ELOVL4—age related macular degeneration	0.00195	0.00195	CbGpPWpGaD
Medroxyprogesterone Acetate—NR3C1—Gene Expression—ERCC6—age related macular degeneration	0.00193	0.00193	CbGpPWpGaD
Medroxyprogesterone Acetate—HSD3B2—Metabolism—CD36—age related macular degeneration	0.00184	0.00184	CbGpPWpGaD
Medroxyprogesterone Acetate—AKR1C3—Metabolism of lipids and lipoproteins—APOE—age related macular degeneration	0.0018	0.0018	CbGpPWpGaD
Medroxyprogesterone Acetate—AKR1C3—Disease—TGFBR1—age related macular degeneration	0.00178	0.00178	CbGpPWpGaD
Medroxyprogesterone Acetate—PGR—Signaling Pathways—RHO—age related macular degeneration	0.00175	0.00175	CbGpPWpGaD
Medroxyprogesterone Acetate—AR—Integrated Breast Cancer Pathway—VEGFA—age related macular degeneration	0.00168	0.00168	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Signaling Pathways—RDH8—age related macular degeneration	0.00168	0.00168	CbGpPWpGaD
Medroxyprogesterone Acetate—AR—SIDS Susceptibility Pathways—VEGFA—age related macular degeneration	0.00164	0.00164	CbGpPWpGaD
Medroxyprogesterone Acetate—HSD3B2—Metabolism—APOE—age related macular degeneration	0.00162	0.00162	CbGpPWpGaD
Medroxyprogesterone Acetate—AKR1C3—Metabolism—LIPC—age related macular degeneration	0.00156	0.00156	CbGpPWpGaD
Medroxyprogesterone Acetate—AKR1C3—Metabolism—CETP—age related macular degeneration	0.00151	0.00151	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Signaling Pathways—RPE65—age related macular degeneration	0.00147	0.00147	CbGpPWpGaD
Medroxyprogesterone Acetate—AR—Integrated Pancreatic Cancer Pathway—VEGFA—age related macular degeneration	0.0014	0.0014	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Integrated Breast Cancer Pathway—VEGFA—age related macular degeneration	0.0013	0.0013	CbGpPWpGaD
Medroxyprogesterone Acetate—AKR1C3—Signaling Pathways—TGFBR1—age related macular degeneration	0.00125	0.00125	CbGpPWpGaD
Medroxyprogesterone Acetate—NR3C1—SIDS Susceptibility Pathways—VEGFA—age related macular degeneration	0.00124	0.00124	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP2C8—Metabolism—NMNAT1—age related macular degeneration	0.00122	0.00122	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Signaling Pathways—ABCA4—age related macular degeneration	0.00118	0.00118	CbGpPWpGaD
Medroxyprogesterone Acetate—AKR1C3—Signaling Pathways—SQSTM1—age related macular degeneration	0.00113	0.00113	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Integrated Pancreatic Cancer Pathway—VEGFA—age related macular degeneration	0.00107	0.00107	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP2C8—Metabolism—ELOVL4—age related macular degeneration	0.00107	0.00107	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Signaling Pathways—RHO—age related macular degeneration	0.00103	0.00103	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP2C9—Metabolism—NMNAT1—age related macular degeneration	0.000992	0.000992	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP2C8—Metabolism of lipids and lipoproteins—LIPC—age related macular degeneration	0.000987	0.000987	CbGpPWpGaD
Medroxyprogesterone Acetate—PGR—Signaling Pathways—TGFBR1—age related macular degeneration	0.000984	0.000984	CbGpPWpGaD
Medroxyprogesterone Acetate—AKR1C3—Disease—APOE—age related macular degeneration	0.000955	0.000955	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP2C8—Metabolism of lipids and lipoproteins—CETP—age related macular degeneration	0.000952	0.000952	CbGpPWpGaD
Medroxyprogesterone Acetate—AKR1C3—Metabolism—CD36—age related macular degeneration	0.000907	0.000907	CbGpPWpGaD
Medroxyprogesterone Acetate—PGR—Signaling Pathways—SQSTM1—age related macular degeneration	0.000892	0.000892	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP2C9—Metabolism—ELOVL4—age related macular degeneration	0.000867	0.000867	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP2C8—Metabolism—SLC16A8—age related macular degeneration	0.000859	0.000859	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP2C9—Metabolism of lipids and lipoproteins—LIPC—age related macular degeneration	0.000803	0.000803	CbGpPWpGaD
Medroxyprogesterone Acetate—AKR1C3—Metabolism—APOE—age related macular degeneration	0.0008	0.0008	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP2C9—Metabolism of lipids and lipoproteins—CETP—age related macular degeneration	0.000775	0.000775	CbGpPWpGaD
Medroxyprogesterone Acetate—AKR1C3—Signaling Pathways—C3—age related macular degeneration	0.000718	0.000718	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP2C9—Metabolism—SLC16A8—age related macular degeneration	0.000699	0.000699	CbGpPWpGaD
Medroxyprogesterone Acetate—AKR1C3—Signaling Pathways—APOE—age related macular degeneration	0.000669	0.000669	CbGpPWpGaD
Medroxyprogesterone Acetate—AKR1C3—Signaling Pathways—KDR—age related macular degeneration	0.000655	0.000655	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP3A4—Metabolism—NMNAT1—age related macular degeneration	0.000654	0.000654	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Signaling Pathways—TGFBR1—age related macular degeneration	0.000577	0.000577	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP2C8—Metabolism of lipids and lipoproteins—CD36—age related macular degeneration	0.000572	0.000572	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP3A4—Metabolism—ELOVL4—age related macular degeneration	0.000572	0.000572	CbGpPWpGaD
Medroxyprogesterone Acetate—PGR—Signaling Pathways—C3—age related macular degeneration	0.000567	0.000567	CbGpPWpGaD
Medroxyprogesterone Acetate—AKR1C3—Signaling Pathways—CCL2—age related macular degeneration	0.000562	0.000562	CbGpPWpGaD
Medroxyprogesterone Acetate—PGR—Signaling Pathways—APOE—age related macular degeneration	0.000528	0.000528	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Signaling Pathways—SQSTM1—age related macular degeneration	0.000524	0.000524	CbGpPWpGaD
Medroxyprogesterone Acetate—PGR—Signaling Pathways—KDR—age related macular degeneration	0.000517	0.000517	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP2C8—Metabolism of lipids and lipoproteins—APOE—age related macular degeneration	0.000505	0.000505	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP2C9—Metabolism of lipids and lipoproteins—CD36—age related macular degeneration	0.000466	0.000466	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP3A4—Metabolism—SLC16A8—age related macular degeneration	0.000461	0.000461	CbGpPWpGaD
Medroxyprogesterone Acetate—PGR—Signaling Pathways—CCL2—age related macular degeneration	0.000443	0.000443	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP2C8—Metabolism—LIPC—age related macular degeneration	0.00044	0.00044	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP2C8—Metabolism—CETP—age related macular degeneration	0.000424	0.000424	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP2C9—Metabolism of lipids and lipoproteins—APOE—age related macular degeneration	0.000411	0.000411	CbGpPWpGaD
Medroxyprogesterone Acetate—AKR1C3—Signaling Pathways—VEGFA—age related macular degeneration	0.000361	0.000361	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP2C9—Metabolism—LIPC—age related macular degeneration	0.000358	0.000358	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP2C9—Metabolism—CETP—age related macular degeneration	0.000345	0.000345	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Signaling Pathways—C3—age related macular degeneration	0.000333	0.000333	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Signaling Pathways—APOE—age related macular degeneration	0.00031	0.00031	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Signaling Pathways—KDR—age related macular degeneration	0.000303	0.000303	CbGpPWpGaD
Medroxyprogesterone Acetate—PGR—Signaling Pathways—VEGFA—age related macular degeneration	0.000285	0.000285	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Signaling Pathways—CCL2—age related macular degeneration	0.00026	0.00026	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP2C8—Metabolism—CD36—age related macular degeneration	0.000255	0.000255	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP3A4—Metabolism—LIPC—age related macular degeneration	0.000236	0.000236	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP3A4—Metabolism—CETP—age related macular degeneration	0.000228	0.000228	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP2C8—Metabolism—APOE—age related macular degeneration	0.000225	0.000225	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP2C9—Metabolism—CD36—age related macular degeneration	0.000207	0.000207	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP2C9—Metabolism—APOE—age related macular degeneration	0.000183	0.000183	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Signaling Pathways—VEGFA—age related macular degeneration	0.000167	0.000167	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP3A4—Metabolism—CD36—age related macular degeneration	0.000137	0.000137	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP3A4—Metabolism—APOE—age related macular degeneration	0.000121	0.000121	CbGpPWpGaD
